Filter News
Area of Research
- (-) Computational Biology (2)
- (-) Electricity and Smart Grid (1)
- Advanced Manufacturing (13)
- Biological Systems (2)
- Biology and Environment (119)
- Biology and Soft Matter (1)
- Building Technologies (2)
- Clean Energy (140)
- Climate and Environmental Systems (2)
- Computational Engineering (3)
- Computer Science (9)
- Energy Sciences (1)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (36)
- Fusion Energy (13)
- Isotope Development and Production (1)
- Isotopes (11)
- Materials (129)
- Materials Characterization (1)
- Materials for Computing (19)
- Materials Under Extremes (1)
- Mathematics (1)
- National Security (32)
- Neutron Science (108)
- Nuclear Science and Technology (43)
- Nuclear Systems Modeling, Simulation and Validation (2)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (94)
- Transportation Systems (1)
News Type
News Topics
- (-) Artificial Intelligence (2)
- (-) Biomedical (2)
- (-) Materials Science (1)
- (-) Neutron Science (1)
- (-) Simulation (1)
- (-) Sustainable Energy (1)
- Biology (2)
- Buildings (1)
- Computer Science (1)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (1)
- Environment (1)
- Frontier (1)
- Grid (3)
- High-Performance Computing (3)
- Machine Learning (1)
- Materials (1)
- Microelectronics (1)
- Summit (1)
Media Contacts
Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.